NEW YORK, Sept. 16, 2016 -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Sizmek, Inc. (“Sizmek” or the “Company”) (Nasdaq: SZMK) in the United States District Court for the Western District of Texas on behalf of current stockholders of Sizmek, seeking to pursue remedies under the Securities Exchange Act of 1934 (the “Exchange Act”).
The Complaint alleges that the Board of Directors of Sizmek breached their fiduciary duties by causing a materially incomplete and misleading Recommendation Statement (the “Recommendation Statement”), to be filed with the SEC. The Complaint further alleges that merger consideration Sizmek stockholders will receive in connection with the transaction does not reflect the fair value of Sizmek shares.
If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected].
Please visit our website at http://www.gme-law.com for more information about the firm.


FTC Antitrust Probe Targets Arm Holdings Over Chip Licensing Practices
YouTube and Snap Settle School District Mental Health Lawsuit Ahead of Major Social Media Trial
Berkshire Hathaway Reveals New Stakes in Delta Air Lines and Macy’s Under Greg Abel
Amazon Faces Class-Action Lawsuit Over Trump Tariff Price Hikes
CXMT Forecasts Record Revenue Growth as Global DRAM Prices Surge
Standard Chartered Targets Higher Profitability With Major Workforce Cuts
Japan Airlines Signs 10-Year Boeing 787 Maintenance Deal With GE Aerospace
Analog Devices Nears $1.5B Acquisition of AI Chip Firm Empower Semiconductor
SpaceX Shareholders Approve 5-for-1 Stock Split Ahead of Potential IPO
Sonova Beats Profit Forecasts Despite Cochlear Implant Weakness
Stellantis CEO Antonio Filosa to Reveal Turnaround Strategy Focused on U.S. Sales and China Partnerships
Samsung Union Talks Enter Final Stage as Strike Threat Looms
Samsung Shares Drop as Labor Union Confirms Planned Strike
Elliott Targets Bio-Rad as Shares Continue to Struggle
TrumpRx Expands Discount Drug Access With 600 Generic Medications
Tencent Shares Jump 4% as AI Models Move Toward Paid Commercial Services 



